US Patent 8008250 Macrocyclic compounds and compositions useful as BACE inhibitors
Patent 8008250 was granted and assigned to Novartis on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+375 characters)
Article
Patent abstract
Macrocyclic compounds of the formula in which R1, R3, V1, V2, X1, X2, Y, Z, Ar, AA and n are as defined in the specification, the number of ring atoms included in the macrocyclic ring being 14, 15, 16, 17 or 18, in free base form or in acid addition salt form, to their preparation, to their use as medicaments and to medicaments comprising them are presented.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008250 Macrocyclic compounds and compositions useful as BACE inhibitors US Patent 8008250 Macrocyclic compounds and compositions useful as BACE inhibitors
Infobox
Patent Number
0800825000
Patent Number
800825000
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080082500
Date of Patent
August 30, 2011
0Patent Application Number
117944120
Date Filed
January 13, 2006
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080082500
Date of Patent
August 30, 2011
0Patent Application Number
117944120
Date Filed
January 13, 2006
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08008250 Macrocyclic compounds and compositions useful as BACE inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08008250
Date of patent
August 30, 2011
Patent application number
11794412
Date Filed
January 13, 2006
Patent primary examiner
Find more entities like US Patent 8008250 Macrocyclic compounds and compositions useful as BACE inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
